Author:
Hiramuki Yosuke,Abe Satoshi,Uno Narumi,Kazuki Kanako,Takata Shuta,Miyamoto Hitomaru,Takayama Haruka,Morimoto Kayoko,Takehara Shoko,Osaki Mitsuhiko,Tanihata Jun,Takeda Shin’ichi,Tomizuka Kazuma,Oshimura Mitsuo,Kazuki Yasuhiro
Abstract
AbstractDystrophin maintains membrane integrity as a sarcolemmal protein. Dystrophin mutations lead to Duchenne muscular dystrophy, an X-linked recessive disorder. Since dystrophin is one of the largest genes consisting of 79 exons in the human genome, delivering a full-length dystrophin using virus vectors is challenging for gene therapy. Human artificial chromosome is a vector that can load megabase-sized genome without any interference from the host chromosome. Chimeric mice carrying a 2.4-Mb human dystrophin gene-loaded human artificial chromosome (DYS-HAC) was previously generated, and dystrophin expression from DYS-HAC was confirmed in skeletal muscles. Here we investigated whether human dystrophin expression from DYS-HAC rescues the muscle phenotypes seen in dystrophin-deficient mice. Human dystrophin was normally expressed in the sarcolemma of skeletal muscle and heart at expected molecular weights, and it ameliorated histological and functional alterations in dystrophin-deficient mice. These results indicate that the 2.4-Mb gene is enough for dystrophin to be correctly transcribed and translated, improving muscular dystrophy. Therefore, this technique using HAC gives insight into developing new treatments and novel humanized Duchenne muscular dystrophy mouse models with human dystrophin gene mutations.
Funder
Science and Technology Platform Program for Advanced Biological Medicine from AMED
JST, CREST
Research Support Project for Life Science and Drug Discovery (BINDS) from AMED
Joint Research of the Exploratory Research Center on Life and Living Systems
Publisher
Springer Science and Business Media LLC
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献